Document Detail

Endothelial Dysfunction and High Cardiovascular Risk Profile in Severe Alcoholics Improve Only Partially Following a Medium-Term Alcohol Withdrawal.
MedLine Citation:
PMID:  22013918     Owner:  NLM     Status:  Publisher    
Background:  Little is known about brachial artery flow-mediated vasodilatation (FMD) in active and medium-term withdrawing heavy alcoholics (HA). Methods:  FMD and some parameters of cardiovascular (CV) risk were measured in 29 HA (average alcohol intake 135, range 86 to 215 g per day) at baseline and after a 9 ± 7 months withdrawal and in 35 teetotalers. Results:  HA showed baseline impaired maximal % FMD (8.5 ± 5.4 SD vs. 14.9 ± 7.4, <0.001 vs. teetotalers), higher systolic (SBP) and diastolic (DBP) blood pressure (+24 mm Hg, <0.001; +15 mm Hg, <0.01), uric acid (5.3 ± 1.1 vs. 4.4 ± 0.8 mg/dl, <0.05), high-sensitivity C-reactive protein (hs-CRP; 2.7 ± 2.0 vs. 1.0 ± 0.9 mg/l, <0.02), endothelin-1 (ET-1, 0.88 ± 0.36 vs. 0.37 ± 0.10 pg/ml,<0.001), asymmetric dimethylarginine (ADMA, 0.50 ± 0.21 vs. 0.41 ± 0.12 μmol/l, p < 0.001), homeostasis model assessment of insulin resistance (HOMA-IR) (2.3 ± 1.1 vs. 1.2 ± 0.4, <0.001), and urinary 8-isoprostane (U8-iso-PGF2α) (237.2 ± 172.4 vs. 168.5 ± 96.6 pg/mg creatinine, <0.05). After withdrawal, SBP fell by 15 mm Hg, DBP by 11 mm Hg (p < 0.001), and hs-CRP by 0.94 mg/l (p < 0.02), all remaining still higher than teetotalers (<0.05, 0.01, 0.05 respectively). ET-1, HOMA-IR, and U8-iso-PGF2α were unchanged (p = NS vs. baseline, <0.05 to 0.001 vs. teetotalers). Maximal % FMD rose (to 10.6 ± 6.2, p < 0.04), but it still remained impaired (<0.04 vs. teetotalers). ADMA increased further to 0.64 ± 0.15 μmol/l (<0.05 vs. baseline, <0.02 vs. teetotalers). Conclusions:  HA show marked endothelial dysfunction (ED) and high BP, impaired insulin sensitivity, inflammation, increased oxidative stress, and elevated ET-1 and ADMA, which are unaffected or only partially reversed by a medium-term alcohol withdrawal. ED and related abnormalities persist in detoxified alcoholics, thus contributing to a greater CV morbidity and mortality.
Cristiana Di Gennaro; Gloria Saccani-Jotti; Silvana Pinelli; Nicola Venturi; Francesca Palombi; Guido Manfredi; Antonina Pellegrino; Lorenza Bicchieri; Paolo Sansoni; Alberto Montanari
Related Documents :
12264858 - Population pressure and land use change: from tree crops to sawah in northwestern kalim...
2390388 - Plastic dental local anaesthetic cartridges: a laboratory investigation.
7869718 - A biphasic poroelastic analysis of the flow dependent subcutaneous tissue pressure and ...
20081668 - Prevention and treatment of pressure ulcers.
6731538 - Pseudophakia and intraocular pressure.
21146228 - Retinal vascular tortuosity, blood pressure, and cardiovascular risk factors.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-20
Journal Detail:
Title:  Alcoholism, clinical and experimental research     Volume:  -     ISSN:  1530-0277     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7707242     Medline TA:  Alcohol Clin Exp Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 by the Research Society on Alcoholism.
From the Centro di Alcologia at the Dipartimento di Medicina Interna e Scienze Biomediche (CD, NV, FP, GM, AP, LB, PS), the Dipartimento di Sanità Pubblica (GS-J), the Dipartimento di Medicina Interna, Nefrologia e Scienze della Prevenzione (SP), and the Dipartimento di Scienze Cliniche (AM), University of Parma Medical School, Parma, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  H<sub>2</sub>O-Broadening of a CO<sub>2</sub> Line and its Nearest Neighbors Near 6360 cm<sup>-1</su...
Next Document:  Palladium-Catalyzed Carbonylative Reaction of 1-(2,2-Dibromovinyl)-2-alkenylbenzene and Carbon Monox...